Ameriprise
EYPT icon

Ameriprise’s EyePoint Inc EYPT Stock Holding History

Ameriprise’s Portfolio EYPT Stock Details EYPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.1M Buy
848,410
+425,148
+100% +$5.69M ﹤0.01% 1915
2026
Q1 		$5.46M Buy
423,262
+209,961
+98% +$3.14M ﹤0.01% 2375
2025
Q4 		$3.9M Buy
213,301
+83,177
+64% +$1.18M ﹤0.01% 2609
2025
Q3 		$1.85M Buy
130,124
+36,049
+38% +$415K ﹤0.01% 3041
2025
Q2 		$885K Sell
94,075
-175
-0.2% -$1.21K ﹤0.01% 3320
2025
Q1 		$511K Buy
94,250
+42,212
+81% +$295K ﹤0.01% 3477
2024
Q4 		$388K Buy
52,038
+27,151
+109% +$253K ﹤0.01% 3617
2024
Q3 		$199K Sell
24,887
-897,032
-97% -$7.88M ﹤0.01% 3758
2024
Q2 		$8.02M Buy
921,919
+248,571
+37% +$3.47M ﹤0.01% 1943
2024
Q1 		$13.9M Sell
673,348
-862,777
-56% -$21.4M ﹤0.01% 1523
2023
Q4 		$35.5M Buy
1,536,125
+1,525,776
+14,743% +$17.1M 0.01% 939
2023
Q3 		$82.7K Buy
+10,349
New +$113K ﹤0.01% 3810
2022
Q3 		– Sell
-63,986
Closed -$504K – 3983
2022
Q2 		$504K Buy
63,986
+3,050
+5% +$30.7K ﹤0.01% 3385
2022
Q1 		$740K Sell
60,936
-300
-0.5% -$3.29K ﹤0.01% 3326
2021
Q4 		$750K Buy
61,236
+37,236
+155% +$501K ﹤0.01% 3380
2021
Q3 		$250K Buy
24,000
+8,600
+56% +$82K ﹤0.01% 3646
2021
Q2 		$138K Buy
+15,400
New +$148K ﹤0.01% 3793

Other funds holding EYPT

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Jupiter Topco
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Paradigm Biocapital Advisors
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Ameriprise's EYPT Position: Q2 2026 in Review

Ameriprise increased its EyePoint Inc (EYPT) stake by 100% in Q2 2026, buying an estimated $5.69M and bringing the position to 848,410 shares worth $12.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1915.

Ameriprise first reported a position in EYPT in Q2 2021 and has held it in 17 quarters since. The position peaked at $35.5M in Q4 2023. 188 funds tracked by Wall St. Rank hold EYPT as of Q2 2026.

  • Ameriprise held 848,410 shares of EyePoint Inc worth $12.1M as of Q2 2026.
  • Ameriprise bought 425,148 EyePoint Inc shares in Q2 2026, an estimated $5.69M.
  • EyePoint Inc made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #1915 holding.
  • Ameriprise first reported a position in EyePoint Inc in Q2 2021 and has held it in 17 quarters since.
  • Ameriprise's EyePoint Inc position peaked at $35.5M in Q4 2023.
  • 188 funds tracked by Wall St. Rank held EyePoint Inc as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.